Table 3.
Absolute and relative measures of all-cause mortality and serious adverse events for the surgical indications in 14,186 shoulder patients and 141,860 matched cohort participants
| Surgical indication | Shoulder patients | Matched cohort | Unadjusted | Adjusted | ||
|---|---|---|---|---|---|---|
| n (%) | IR (CI) | n (%) | IR (CI) | IRR (CI) | IRR a (CI) | |
| 30-days mortality | ||||||
| Total | 86 (0.6) | 20.3 (16.4–25.0) | 401 (0.3) | 9.4 (8.6–10.4) | 2.2 (1.7–2.7) | 2.0 (1.6–2.5) |
| Fracture | 68 (1.2) | 41.0 (32.3–52.0) | 4.3 (3.4–5.6) | 3.5 (2.7–4.6) | ||
| OA and CTA | 8 (0.2) | 3.6 (1.8–7.2) | 0.4 (0.2–0.8) | 0.4 (0.2–0.8) | ||
| Other | 10 (0.9) | 28.9 (15.6–53.7) | 3.1 (1.6–5.7) | 2.5 (1.3–4.7) | ||
| 30-days SAE | ||||||
| Total | 307 (2.2) | 73.5 (65.7–82.2) | 629 (0.4) | 14.8 (13.7–16.0) | 5.0 (4.3–5.7) | 4.6 (4.0–5.3) |
| Fracture | 166 (3.0) | 102.1 (87.7–118.9) | 6.9 (5.8–8.2) | 5.9 (5.0–7.1) | ||
| OA | 61 (1.2) | 39.8 (31.0–51.2) | 2.7 (2.1–3.5) | 3.1 (2.4–4.0) | ||
| CTA | 50 (2.2) | 73.5 (55.7–97.0) | 5.0 (3.7–6.6) | 3.7 (2.8–5.0) | ||
| Other | 30 (2.6) | 87.9 (61.4–125.7) | 5.9 (4.1–8.5) | 4.8 (3.3–7.0) | ||
| 90-days mortality | ||||||
| Total | 197 (1.4) | 15.6 (13.5–17.9) | 1,107 (0.8) | 8.7 (8.2–9.2) | 1.8 (1.5–2.1) | 1.7 (1.4–1.9) |
| Fracture | 146 (2.6) | 29.6 (25.1–34.8) | 3.4 (2.9–4.0) | 2.8 (2.3–3.3) | ||
| OA | 15 (0.3) | 3.2 (2.0–5.4) | 0.4 (0.2–0.6) | 0.5 (0.3–0.8) | ||
| CTA | 8 (0.4) | 3.9 (1.9–7.7) | 0.4 (0.2–0.9) | 0.3 (0.2–0.7) | ||
| Other | 28 (2.4) | 27.2 (18.8–39.4) | 3.1 (2.2–4.6) | 2.7 (1.9–3.9) | ||
| 90-days SAE | ||||||
| Total | 470 (3.3) | 37.9 (34.7–41.5) | 1,731 (1.2) | 13.7 (13.1–14.3) | 2.8 (2.5–3.1) | 2.6 (2.3–2.8) |
| Fracture | 264 (4.7) | 55.1 (48.8–62.2) | 4.0 (3.5–4.6) | 3.5 (3.1–4.0) | ||
| OA | 91 (1.78) | 19.9 (16.2–24.4) | 1.5 (1.2–1.8) | 1.6 (1.3–2.0) | ||
| CTA | 73 (3.2) | 36.1 (28.7–24.4) | 2.3 (2.1–3.3) | 2.0 (1.6–2.5) | ||
| Other | 42 (3.6) | 41.8 (30.9–56.5) | 3.1 (2.2–4.2) | 2.6 (1.9–3.5) | ||
| 1-year mortality | ||||||
| Total | 507 (3.6) | 10.0 (9.2–10.9) | 4,444 (3.1) | 8.7 (8.5–9.0) | 1.2 (1.1–1.3) | 1.1 (1.0–1.2) |
| Fracture | 341 (6.1) | 17.4 (15.7–19.3) | 2.0 (1.8–2.2) | 1.6 (1.5–1.8) | ||
| OA | 50 (0.9) | 2.7 (2.0–3.5) | 0.3 (0.2–0.4) | 0.4 (0.3–0.5) | ||
| CTA | 34 (1.5) | 4.1 (2.9–5.7) | 0.5 (0.3–0.7) | 0.3 (0.2–0.5) | ||
| Other | 82 (7.1) | 20.2 (16.3–25.1) | 2.3 (1.9–2.9) | 2.1 (1.6–2.6) | ||
CI: 95% confidence interval; CTA: rotator cuff tear arthropathy; IR: incidence rate per 100,000 person-days; IRR: incidence rate ratio per 100,000 person-days. OA: osteoarthritis.
a
Adjusted for sex, age, and Charlson comorbidity index.